Back to Search Start Over

Targeting Rho kinase to restore endothelial barrier function following vascular scaffold implantation.

Authors :
Tesfamariam B
Source :
Drug discovery today [Drug Discov Today] 2023 Jul; Vol. 28 (7), pp. 103609. Date of Electronic Publication: 2023 May 06.
Publication Year :
2023

Abstract

Vascular scaffold implantation induces injury to the intimal layer and causes discontinuity of the regenerated endothelial monolayer, compromising barrier integrity, increasing permeability, and allowing the transmigration of leukocytes and lipoproteins into the subendothelial space. Mechanical vascular wall stretching triggers Ras homolog family member A (RhoA)/Rho kinase-mediated actomyosin contractility and destabilization of adherens junctions, leading to endothelial barrier dysfunction. Assembly of intercellular adhesion and actin cytoskeletal organization of interendothelial junctions are controlled by downregulation of RhoA guanosine triphosphatase (GTPase)-mediated barrier-disruptive activity and upregulation of repressor-activator protein 1 (Rap1) and Ras-related C3 botulinum toxin substrate 1 (Rac1) GTPase-mediated cytoskeletal reorganization, leading to endothelial barrier stabilization. This review highlights the involvement of Rho GTPases in the disruption of endothelial barrier integrity following vascular scaffold implantation and the targeting of downstream Rho-associated protein kinases, which signal the network to restore endothelial barrier integrity and stability.<br /> (Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1878-5832
Volume :
28
Issue :
7
Database :
MEDLINE
Journal :
Drug discovery today
Publication Type :
Academic Journal
Accession number :
37150436
Full Text :
https://doi.org/10.1016/j.drudis.2023.103609